Future studies addressing the relevance of the cancer status of PTEN and CK2 in primary patient GBMs samples, and crosstalk and regulation of DNA damage sensing and repair pathway choice by PTEN via CK2 and/or other intersecting oncogenic pathways, may further aid to identify new therapeutic targets or methods of therapeutic intervention for this deadly disease. Here, PTEN is linked to cancer.